Biphasic Mesothelioma Cancer Cell

Biphasic Mesothelioma

Mesothelioma Cancer Cell

Biphasic mesothelioma is number second most common mesothelioma cell after epithelioid mesothelioma cancer cell, counting about 20% to 40% of all mesothelioma cases. However, this mesothelioma cell apparently increase every year, and counting up to 65%. From the name we know that biphasic mesothelioma cancer cell is a combined cell from two mesothelioma cancer cells.

Unlike epithelioid and sarcomatoid mesothelioma cells, biphasic mesothelioma does not really have a specific form. Biphasic mesothelioma cancer is a combination of epithelioid and sarcomatoid mesothelioma cancer cells. Epithelioid mesothelioma cell has cubed shape and sarcomatoid mesothelioma has spindle or oval shaped. Although both mesothelioma types are present in a biphasic tumor, they have a tendency to form in differentiated groups; they are not usually found in the same area of the tumor.


Classifying a case of mesothelioma as biphasic is simply stating that the patient has both epithelioid and sarcomatoid mesothelioma cancer. When epithelioid and sarcomatoid cancer cells are separated throughout various parts of the tumor, it can lead to a misdiagnosis of the mesothelioma subtype.

Biphasic Mesothelioma Cancer Cell Diagnosis

The biphasic mesothelioma cell diagnosis maybe difficult since the examination of the tumor may only uncover epithelioid or sarcomatoid mesothelioma cells. By taking multiple sections of diseased tissue for examination, histopathologists are more likely to be able to identify a case of biphasic mesothelioma cancer. However, mesothelioma cells misdiagnosis may not a problem because the treatments among three mesothelioma cells are apparently same.

Biphasic Mesothelioma Cancer Cell Treatment

Biphasic mesothelioma cancers, sarcomatoid mesothelioma cancer and epithelioid treatment are the same. But the prognosis associated with each mesothelioma cell is different, as the average survival time. The mean survival time of biphasic mesothelioma cancer patients (six months) is the lowest of the three.

Main article - Sarcomatoid Mesothelioma Cancer Cell